Anoat Therapeutics
About:
Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
Top Investors: AdBio partners
Description:
Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
Total Funding Amount:
2M EUR
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2023-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-06-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai